Live Updates No News Is Good News4:18pm ETThe trading day has ended, and the Federal Reserve meeting, too. As expected, the Fed once again decided to leave interest rates unchanged at a…
Live Updates S&P 500 Extends Its Winning Streak4:18pm ETThe S&P 500 closed up 0.6% for Tuesday, extending its winning streak to six straight days. Trade Talks Keep S&P 500 Moving Higher1:51pm ET“Ask,…
Eli Lilly (NYSE:LLY | LLY Price Prediction) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 trillion stock and the first healthcare…
Live Updates All's Well That Ends Green4:30pm ETAll three major market indices ended in the green Friday. The Dow Jones Industrial Average closed up a bare 0.05%, while the S&P 500 gained…
Live Updates A Bad Day for Investors Got Much, Much Worse4:08pm ETA trading day that started out bad for investors this morning ended in a market rout. By the time the closing…
One man’s trash may be another man’s treasure, but dumpster diving when investing carries risks. You have to wade through a lot of junk to potentially find a nugget of gold. While…
Dividend stocks have been a reliable cornerstone for those who want to anchor their portfolios when markets get shaky. These stocks give you a steady stream of income and often appreciate during…
Shares of Hims & Hers Health (NASDAQ:HIMS) continued to meltdown Tuesday in noontime trading after the direct-to-consumer healthcare platform said it couldn’t guarantee it would be able to continue selling its knockoff…
The Food & Drug Administration announced last week that the Ozempic and Wegovy shortage for Novo Nordisk‘s (NYSE:NVO | NVO Price Prediction) was over. It said the Danish pharmaceutical had sufficient supply…
Shares of Hims & Hers Health (NYSE:HIMS) are down about 21%, or $14. All on news the Ozempic shortage is over. About This Article Just this morning, the US FDA said Novo…
AbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50 years.
The biotech scene can be seen as fairly risky for new investors who want to put money to work. After all, it’s really tough to gauge which innovative biotech firms will have…
Eli Lilly (NYSE: LLY | LLY Price Prediction) doesn’t really need much of an introduction. It has become a household name due to its obesity and diabetes treatments. LLY stock has delivered…
Palantir Technologies (NASDAQ:PLTR | PLTR Price Prediction) has been described as the best pure-play stock in artificial intelligence. The market agrees, sending shares of PLTR stock some 342% higher over the past…
Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli Lilly (NYSE:LLY | LLY Price Prediction) has become the industry leader in a…
